Tag: Zephyr® Endobronchial Valve

A new study has revealed that endobronchial valves – tiny, one-way valves placed in the lungs to block airflow to diseased regions in order to achieve lung volume reduction – can benefit patients with homogeneous emphysema (emphysema distributed evenly across the lung). In the IMPACT study, Pulmonx Corporation’s proprietary Zephyr Endobronchial Valves (EBV) were placed in the lungs of 93 patients with severe homogeneous emphysema, in order
APPROVAL #13041956.1 FOR IMMEDIATE RELEASE MEDIA CONTACT Michelle McAdam, Chronic Communications michelle@chronic-comm.com, (310) 902-1274 NEW CLINICAL TRIAL AT LA BIOMED/HARBOR-UCLA AND USC OFFERS HOPE FOR EMPHYSEMA PATIENTS Investigational Treatment May Help Lungs Function More Effectively Without Surgery, Enabling Better Breathing and Quality of Life LOS ANGELES, Calif. – June 4, 2015 – A clinical trial for patients suffering from severe e